• Recruiting

The clonoSEQ® Watch Registry

Updated: May 24

The clonoSEQ® Watch Registry


Real World Observational Study Using clonoSEQ® Next Generation Sequencing in Hematologic Malignancies: The 'Watch' Registry

clonoSEQ

This is a prospective, multicenter, observational study of adult patients with a diagnosis of acute lymphoblastic leukemia (ALL), multiple myeloma (MM), chronic lymphocytic leukemia (CLL), or non-Hodgkin lymphoma (NHL). This study will enroll up to 528 patients in up to 50 sites in the United States and collect data with regard to use of the clonoSEQ MRD assay in the management of lymphoid malignancies.


Diagnostic Test

clonoSEQ Assay


Sponsor

Adaptive Biotechnologies

 

ClinicalTrials.gov Identifier: NCT04545333


Official Title: Real World Observational Study Using clonoSEQ® Next Generation Sequencing in Hematologic Malignancies: The 'Watch' Registry


First Posted: September 11, 2020


Click here for details on ClinicalTrials.gov

 

- Multiple Locations

 

Locations


United States, California

United States, Colorado

United States, District of Columbia

United States, Florida

United States, Illinois

United States, Louisiana

United States, Maryland

United States, Missouri

United States, North Carolina

United States, Oregon

United States, Pennsylvania

United States, South Carolina

United States, Washington






Posts Archive